Great pullback - now the fun begins
CRSP is leader in Genomics and this recent pullback is a perfect buying opportunity for new entrants. If our Elliott wave impulse thesis plays out, the next target could be $290. LONG
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。